Document is current
Any future updates will be listed below
-
Authors
Trager, Megan H.
Geskin, Larisa J.
Saenger, Yvonne M.
- License Information
-
More Information
Article History
First Online: 19 March 2020
Compliance with Ethical Standards
:
: Megan H. Trager declares that she has no conflict of interest.Larisa J. Geskin has received research funding from Helsinn Therapeutics, Mallinckrodt, Medivir, Soligenix, and Kyowa Hakko Kirin and has received compensation from Helsinn Therapeutics, Mallinckrodt, Medivir, and Therakos for service as a consultant.Yvonne M. Saenger has received research funding for clinical and laboratory research from Amgen and has a patent on immune signatures for melanoma recurrence pending.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
